ARTICLES LIST

 

Total Results: 16203

Media ID Source Name Media Type Language Media Name Media Description Keywords Keywords Link to Article
1420 National Cancer Institute Html en Prostate Cancer Prevention (PDQ®)–Health Professional Version Expert-reviewed information summary about factors that may influence the risk of developing prostate cancer and about research aimed at the prevention of this disease.
hereditary prostate cancer0.542395
prostate biopsy0.533126
dutasteride group vs0.459041
skin cancer0.446356
prostate cancer period0.528407
cancer mortality rates0.459369
prostate volume subgroups0.508967
Prostate Cancer Events0.558338
finasteride group versus0.448086
rat ventral prostate0.516053
high-grade tumors0.479135
high-grade cancer0.454168
prostate cancer-specific mortality0.525559
occult prostate cancer0.561891
high-grade prostate cancer0.548137
prostate preventive effects0.507979
relative risk reduction0.446967
radical prostatectomy0.460894
prostate cancer mortality0.534065
prostate cancer chemoprevention0.531007
dietary fat0.445789
men0.4492
Cancer Events trial0.451937
negative prostate biopsy0.515564
digital rectal examination0.454846
dutasteride group0.460003
fat intake0.450377
Cancer Prevention Trial0.500983
prostate digital0.500034
prostate cancer risk0.564597
placebo group0.469544
incident prostate cancer0.532469
Cancer Events study0.447937
prostate volume0.517049
absolute risk reduction0.495169
low biologic risk0.447169
finasteride group0.448145
prostate cancer0.910772
Gleason0.458954
clinical prostate cancer0.556069
pancake-appearing prostate0.508749
Prostate Cancer Prevention0.595277
prostate cancer.0.505972
prostate cancer death.0.562581
statistically significant difference0.470146
prostate cancers0.559985
human prostate cancer0.538634
CLICK HERE
1458 National Cancer Institute Html en Cigarette Smoking: Health Risks and How to Quit (PDQ®)–Patient Version Expert-reviewed information summary about research and guidelines focused on the prevention and cessation of cigarette smoking.
cancer treatment0.511187
cancer prevention trials0.526349
prevention clinical trials0.527895
protective factors0.503231
new cancers0.484789
nicotine withdrawal symptoms0.507568
PDQ cancer information0.671083
lung cancer0.635933
Lung Health Study0.490849
clinical trials0.665449
cancer information summary0.600276
health care professionals0.488661
clinical trial0.538396
breast cancer prevention0.507807
PDQ summaries0.484382
Childhood cancer survivors0.595809
smoking reduction0.509721
cancer risk factor0.545024
NCI’s PDQ0.484019
NCI PDQ cancer0.553403
health problems0.510567
cancer recurrence0.485421
nicotine replacement products0.747838
nicotine replacement product0.508467
Cancer prevention0.618116
cancer protective factor0.526183
smokers0.498248
Cancer Information Service0.517443
smoking0.827105
Prevention Editorial Board0.530978
treatment clinical trials0.488401
National Cancer Institute0.611044
cancer death0.488965
health care0.546707
new treatment0.493726
PDQ Cigarette Smoking0.572693
Cancer Care page0.508742
PDQ database0.482266
health0.549208
childhood cancer survivor0.513387
people0.5314
PDQ summary0.514038
nicotine gum0.499264
cancer clinical trials0.526839
risk factors0.570886
Public Health Service0.486542
cancer information summaries0.523287
comprehensive cancer information0.523579
CLICK HERE
1555 National Cancer Institute Html en Chronic Myelogenous Leukemia Treatment (PDQ®)–Patient Version Expert-reviewed information summary about the treatment of chronic myelogenous leukemia.
red blood cells0.704307
cancer treatment0.518767
blast cells0.52224
blast cells increases0.484236
following PDQ summaries0.473092
PDQ cancer information0.548139
clinical trial search0.530856
bone marrow disease0.473382
white blood cells0.672062
donor stem cell0.54478
clinical trials0.856546
mature blood cells0.534844
cancer information summary0.513437
clinical trial0.70787
stem cell transplant0.622548
patients0.481704
blood cells0.749352
chronic myelogenous leukemia0.997869
immature cells0.473394
treatment clinical trial0.482118
NCI PDQ cancer0.480305
Treatment Editorial Board0.48584
tyrosine kinase inhibitor0.593512
treatment0.640788
myeloid stem cell0.492405
stored stem cells0.491127
immature blood cells0.498369
blood stem cell0.484429
tyrosine kinase0.602514
NCI-supported cancer0.478389
cancer cells0.519678
lymphoid stem cell0.493179
specific cancer cells0.502587
tyrosine kinase inhibitors0.484134
stem cell0.637917
treatment clinical trials0.506841
blood stem cells0.543194
National Cancer Institute0.512761
healthy white blood0.495783
new treatment0.554317
white blood cell0.525778
chronic granulocytic leukemia0.476374
bone marrow0.760079
blastic phase0.485946
cancer clinical trials0.539698
cancer0.652333
information0.55566
Myelogenous Leukemia Treatment0.486009
standard treatment0.485468
CLICK HERE
1618 National Cancer Institute Html en Late Effects of Treatment for Childhood Cancer (PDQ®)–Patient Version The treatment of cancer may cause health problems (late effects) for childhood cancer survivors months or years after successful treatment has ended. Get information about the long-term physical, psychological and social effects of treatment for childhood cancer in this expert-reviewed summary.
childhood cancers0.431043
cancer treatment0.371211
body0.373967
childhood cancer survivors0.770496
chemotherapy0.372336
PDQ cancer information0.35879
total-body irradiation0.354372
ovarian late effects0.364333
bile duct0.348106
talk0.386582
chest radiation treatment0.353115
kidney late effects0.373747
joint late effects0.365129
cancer information summary0.349224
stem cell transplant0.480939
pancreatic late effects0.367016
heart0.364096
symptoms0.373794
health problems0.529948
tests0.430651
primary cancer diagnosis0.352818
radiation therapy0.438948
following0.347799
hormone replacement therapy0.348511
late effects0.94258
treatment0.571093
blood vessel0.385075
primary cancer0.359907
signs0.42599
related health problems0.511763
procedures0.374731
National Cancer Institute0.350345
spinal cord0.453656
disease0.351393
breast cancer risk0.350432
breast cancer0.372761
brain tumor0.349819
thyroid late effects0.395111
brain0.380353
doctor0.354325
radiation treatment0.379126
radiation0.476283
acute lymphoblastic leukemia0.349699
health habits0.363956
neuroendocrine late effects0.359016
high blood pressure0.347712
nonmelanoma skin cancer0.356812
lung late effects0.390136
CLICK HERE
1649 National Cancer Institute Html en Aromatherapy and Essential Oils (PDQ®)–Patient Version Expert-reviewed information summary about the use of aromatherapy and essential oils to improve the quality of life of cancer patients.
PDQ Aromatherapy0.51751
cancer treatment0.518478
modern aromatherapy0.502296
certain essential oils0.545828
aromatherapy training0.496531
PDQ cancer information0.582174
Cancer Complementary0.49782
hormone -like effects0.496783
clinical trials0.646919
cancer information summary0.54045
aromatherapy massage0.496545
alternative cancer therapies0.488792
clinical trial0.515897
CAM cancer research0.479249
patients0.520207
cancer patients0.499565
Aromatherapy products0.529674
bergamot essential oil0.494855
literature discuss aromatherapy0.518185
NCI PDQ cancer0.50787
cancer information database0.486869
aromatherapy0.710126
international aromatherapy programs0.515466
Therapies Editorial Board0.490712
essential oils0.964677
cancer information0.591001
treatment0.540034
Complementary Therapies Editorial0.514222
Drug Administration0.547203
Cancer Information Specialist0.481775
Aromatherapy research0.515581
tree essential oils0.64448
Cancer Information Service0.537651
tree essential oil0.496279
Antibacterial essential oils0.531896
National Cancer Institute0.639762
alternative medicine0.561892
standard aromatherapy certification0.518782
term aromatherapy0.502247
orange essential oil0.494346
aromatherapy courses0.496618
tea tree0.549957
cancer clinical trials0.48888
alternative therapies0.505894
ginger essential oil0.493305
cancer information summaries0.487611
cancer0.667969
Holistic Aromatherapy0.506338
CLICK HERE
2015 National Cancer Institute Html es Prevención del cáncer de pulmón (PDQ®)–Versión para pacientes Sumario de información revisada por expertos sobre factores que influirían en el riesgo de presentar cáncer de pulmón y sobre las investigaciones dirigidas a la prevención de esta enfermedad.
cigarrillo encendido0.533546
voluntarios sanos0.521783
secciones llamadas lóbulos0.564444
factor protector0.54356
rayos x0.525531
rayos gamma0.526755
altas cantidades0.523911
vías respiratorias0.534485
suplementos vitamina0.527073
membrana delgada llamada0.563077
National Cancer Institute0.526876
Más personas0.538369
Instituto Nacional0.548081
antecedentes familiares0.770813
siguientes factores0.598507
Physician Data Query0.601335
gas radón0.544843
prevención revisa0.523285
PDQ Prevención0.542908
siguientes sustancias0.533013
Menor exposición0.544963
órganos respiratorios0.535883
principal causa0.53309
factores protectores0.947087
siguientes sumarios0.567797
suplementos alimenticios0.525893
CLICK HERE
2037 National Cancer Institute Html es Prevención del cáncer de piel (PDQ®)–Versión para profesionales de salud Sumario de información revisada por expertos sobre factores que pueden influir en el riesgo de presentar cáncer de piel y sobre las investigaciones dirigidas a prevenir esta enfermedad.
skin cancer0.991265
cutaneous melanoma0.469757
Lippincott Williams0.41932
skin cancer prevention0.612003
prevent skin0.440602
protectores solares0.469609
Williams GM0.418343
queratosis solares0.585992
Sin embargo0.685934
protector solar0.843096
American Cancer Society0.553421
Prev Med0.458565
cancer prevention study0.448174
case-control study0.424296
Study Group0.427125
DeVita VT Jr0.43478
risk factors0.435855
with nonmelanoma skin0.42056
isotretinoin-basal cell carcinomas0.418488
randomized trial0.462527
exposición solar0.710997
Natl Cancer Inst0.487884
8th ed0.41947
protección solar0.624745
melanoma risk factors0.418328
pruebas insuficientes0.419855
Nambour Skin Cancer0.466485
cell carcinomas0.512878
Halliday GM0.422507
Arch Dermatol0.425176
Wilson LD0.417928
Cancer Facts0.43005
Aasi SZ0.421096
nevos melanocíticos benignos0.418665
protector solar ayuda0.422241
controlled trial0.45893
protector solar versus0.425736
Epidemiol Biomarkers Prev0.463973
exposición solar aguda0.467654
Cancer Prevention Trial0.454925
Thomas VD0.418204
Reduce Actinic Cancer0.419285
radiación uv0.425436
randomized controlled trial0.440826
radiación solar0.432514
crema base0.420169
nonmelanoma skin cancer0.715174
radiación ultravioleta0.572893
Cancer Study Group0.420229
CLICK HERE
2072 National Cancer Institute Html es Teléfonos celulares y el riesgo de cáncer Hoja informativa que resume la evidencia disponible acerca del uso de los teléfonos celulares y el riesgo de cáncer.
CERENAT case-control study0.411745
multicenter case-control study0.411414
epidemiological study results0.41093
rayos x0.411877
brain glucose metabolism0.429587
case-control study0.426606
único efecto0.412309
tumores benignos0.415961
GSM mobile0.415087
incidence trends0.411018
Ningún estudio0.417181
y el riesgo0.411067
estudio cerecat0.417392
nationwide cohort study0.411491
estudio cefalo0.417908
NCI evaluó la incidencia0.412387
Schüz J0.443349
posibles efectos0.437506
Estudio Danés0.41724
Estados Unidos0.572662
teléfonos análogos0.439875
teléfonos celulares. Todavía0.442397
PubMed Abstract0.994162
ambicioso estudio0.416033
menor riesgo0.411527
Danish cohort study0.411708
mobile phone0.603266
International Agency0.410998
cerebral blood flow0.418576
Johansen C0.418262
International Journal0.433338
malignant brain tumours0.413167
estudio conjunto0.41602
cohort study0.416338
Deltour I0.41865
British Medical Journal0.421146
brain neoplasms0.419629
brain tumor risk0.416486
brain tumours0.444382
teléfonos celulares y tumores0.450845
participantes controles0.41861
international case-control study0.411613
sistema nervioso central0.469236
brain tumor0.443081
cerebro quizás0.419107
Cancer Institute0.432735
teléfonos celulares causa0.474528
pequeños estudios0.411116
teléfonos celulares análogos0.479549
CLICK HERE
3581 National Cancer Institute Html en Cancer Screening and Early Detection Research Information about cancer screening and early detection research, including a summary of NCI programs dedicated to advancing screening and early detection.
new screening test0.540118
cancer deaths0.410053
NCI family studies0.383067
lung cancer0.420741
Breast Cancer Surveillance0.38723
regular screening0.445893
colorectal cancer screening0.603772
early detection0.939503
certain cancers0.363738
nonhereditary cancers0.350447
cancer diagnosis0.409297
Early Detection Research0.39067
Colorectal Cancer Outreach0.419418
invasive diagnostic tests0.349791
cervical cancer0.470854
Reduce Cancer Health0.403575
follow-up screening0.454414
population groups0.405687
cancers0.545666
effective screening tests0.700094
cancer screening0.952427
esophageal cancer0.349174
cancer prevention0.403966
cancer screening practices0.592194
United States0.470337
screening tests0.828502
early detection tests0.394525
Cancer Treatment0.361701
cancer cells0.354406
new screening tests0.532154
successful screening approach0.50247
annual screening0.507755
screening clinical trials0.513432
National Lung Screening0.514111
breast cancer screening0.628104
potentially lethal cancers0.414445
advanced cancer0.354994
Research Optimizing Screening0.517143
screen-detected cancers0.368122
cancer screening tests0.606127
CT-based screening0.448353
hereditary cancers0.34998
lung cancer risk0.409654
false-positive screening tests0.535547
Screening Initiative0.447841
cancer mortality0.418544
screening methods0.487692
Cancer Screening Trial0.590657
life-threatening cancers0.360993
CLICK HERE
16374 National Cancer Institute Html en Cancer Moonshot℠ – Funding Opportunities NCI is accepting applications for research grants that support the Cancer Moonshot Blue Ribbon Panel recommendations to accelerate cancer research.
Cancer Drug Resistance0.295868
Science Network Cancer0.308038
Human Tumor Atlases0.404045
Immunotherapy Translational Science0.984441
Science Accelerating Colorectal0.287912
Fusion Oncoproteins0.307628
Cancer Immunoprevention Research0.286973
Cancer Immunotherapy Translational0.970237
Network Pediatric Immunotherapy0.362271
Pediatric Immunotherapy Discovery0.349074
Tumor Atlases Human0.296142
Implementation Science Improving0.29186
Translational Science Network0.875874
Management Research Research0.283205
New Enabling Technologies0.348633
Network Metabolic Reprogramming0.28898
Immuno-Oncology Translation Network0.34437
Promote Research Collaborations0.285621
Science Improving Smoking0.284218
Colorectal Cancer Screening0.294277
Research Projects0.27874
Cancer Data Ecosystem0.284367
Science Network Metabolic0.302007
Cancer Moonshot0.286234
Network Canine Immunotherapy0.334919
Implementation Science Accelerating0.293234
PHS2018-1/ Topic0.305631
Research Centers0.280481
Network Immuno-Oncology Translation0.344385
Cancer Immunotherapy Research0.375931
Symptom Management Research0.365508
Childhood Cancers0.296073
Science Network Research0.294604
Early Detection0.350699
Accelerating Colorectal Cancer0.296449
National Cancer Data0.285248
Science Network Coordinating0.277495
Network Cancer Immunologic0.279507
Canine Immunotherapy Trials0.339278
Network Cancer Immune0.278836
Translational Studies0.295595
Human Tumor Atlas0.288789
Translational Research0.303812
Cancer Moonshot-related activities0.277278
Immunotherapy Data Resource0.338479
Atlases Human Tumor0.296132
Science Network Pediatric0.294096
Science Network Immuno-Oncology0.350197
Implementation Science0.370631
CLICK HERE

 

 

 

Terms of Use | Privacy Policy
©2017 ARCHES Technology. All Rights Reserved.